Global Financial Private Capital’s United Therapeutics UTHR Stock Holding History

Global Financial Private Capital’s Portfolio UTHR Stock Details UTHR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	$74K	Buy	+615	New	+$69.2K	﹤0.01%	259

Other funds holding UTHR

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Global Financial Private Capital's UTHR Position: Q2 2020 in Review

Global Financial Private Capital opened a new position in United Therapeutics (UTHR) in Q2 2020: 615 shares worth $74K. The stake represents ﹤0.01% of the portfolio and ranks #259 among its holdings.

349 funds tracked by Wall St. Rank hold UTHR as of Q2 2020.

Global Financial Private Capital held 615 shares of United Therapeutics worth $74K as of Q2 2020.
United Therapeutics was a new Global Financial Private Capital position in Q2 2020.
United Therapeutics made up ﹤0.01% of Global Financial Private Capital's portfolio in Q2 2020, its #259 holding.
349 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2020.

Based on Global Financial Private Capital's 13F filing for Q2 2020, filed 11 Aug 2020.